Post-traumatic stress disorder

FHE Health Named “Preferred Provider” by the National Staff Organization

Friday, April 9, 2021 - 9:02pm

The world's largest union representing union staff, the National Staff Organization (NSO), has officially named FHE Health their "preferred and recommended provider."

Key Points: 
  • The world's largest union representing union staff, the National Staff Organization (NSO), has officially named FHE Health their "preferred and recommended provider."
  • The designation of the national behavioral health organization FHE Health as "program of choice" comes at a time when undue stress has burdened union executives who are further positioning themselves to meet members needs.
  • The NSO has recommended FHE Health for mental and behavioral health services and as a union-side Employee Assistance Program to prioritize and protect members' health.
  • FHE Health will also serve as the primary, acute inpatient care provider for PTSD , addiction and other mental health services.

Heroic Dose Event Explores Promise of Psychedelic Medicine for Veterans, Military & Servicemen and Women

Thursday, April 8, 2021 - 1:00pm

Toronto, Ontario--(Newsfile Corp. - April 8, 2021) - Microdose Psychedelic Insights , along with Entheon Biomedical Corp. , Bexson Biomedical , HavnLife and The Conscious Fund , present the Heroic Dose .

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - April 8, 2021) - Microdose Psychedelic Insights , along with Entheon Biomedical Corp. , Bexson Biomedical , HavnLife and The Conscious Fund , present the Heroic Dose .
  • The Heroic Dose will commence on 22nd April at 8:45 am EST.
  • This one-day virtual conference explores the use of psychedelic therapies for military veterans and first responders in an effort to combat the alarming rates of PTSD, substance abuse and suicide in this valuable yet underserved demographic.
  • This conference will feature some of the finest Navy SEAL and national security professionals, veterans and other servicemen and women, along with knowledgeable experts in psychedelic therapy, researchers, clinicians, companies, advocates.

Why Mainstream Mental-Health Care is Embracing Psilocybin - Alternative Active Substances

Wednesday, March 31, 2021 - 1:30pm

While the study of psychedelics as medicine, all across the globe, is inching toward the mainstream, it still remains somewhat controversial.

Key Points: 
  • While the study of psychedelics as medicine, all across the globe, is inching toward the mainstream, it still remains somewhat controversial.
  • A recent article on WIRED (UK) projected that Psychedelic medicine will begin to cross over into the mental health mainstream in 2021.
  • "In both Europe and the US, medicines regulators have eased restrictions on using MDMA to treat post-traumatic disorder (PTSD), and on psilocybin the active substance in magic mushrooms to treat depression.
  • In the UK, London-based mental-health care company COMPASS Pathways has raised more than $115m to fund its efforts and bring to market a psilocybin treatment for depression.

Why Mainstream Mental-Health Care is Embracing Psilocybin - Alternative Active Substances

Wednesday, March 31, 2021 - 1:30pm

While the study of psychedelics as medicine, all across the globe, is inching toward the mainstream, it still remains somewhat controversial.

Key Points: 
  • While the study of psychedelics as medicine, all across the globe, is inching toward the mainstream, it still remains somewhat controversial.
  • A recent article on WIRED (UK) projected that Psychedelic medicine will begin to cross over into the mental health mainstream in 2021.
  • "In both Europe and the US, medicines regulators have eased restrictions on using MDMA to treat post-traumatic disorder (PTSD), and on psilocybin the active substance in magic mushrooms to treat depression.
  • In the UK, London-based mental-health care company COMPASS Pathways has raised more than $115m to fund its efforts and bring to market a psilocybin treatment for depression.

Jonathan Covey MD, JD is recognized by Continental Who's Who

Tuesday, March 30, 2021 - 8:36pm

COLORADO SPRINGS, Colo., March 30, 2021 /PRNewswire/ --Jonathan Covey MD, JD, is being recognized by Continental Who's Who as a Top Psychiatrist for his professional excellence in the field of Psychiatry and his outstanding leadership within his practice.

Key Points: 
  • COLORADO SPRINGS, Colo., March 30, 2021 /PRNewswire/ --Jonathan Covey MD, JD, is being recognized by Continental Who's Who as a Top Psychiatrist for his professional excellence in the field of Psychiatry and his outstanding leadership within his practice.
  • Covey is currently offering telemedicine services in the state of Colorado.
  • He offers a vast repertoire of valuable knowledge and experience in mood disorders, anxiety, bipolar, ADHD, depression, anxiety, PTSD, and more.
  • Covey completed his undergraduate studies at Sanford University and received his Juris Doctor degree.

Navy SEALs and Families Connect with CommScope

Tuesday, March 30, 2021 - 1:05pm

CommScope today announced the collaboration with smart home system provider Audio Impact to bring reliable Wi-Fi connectivity to Navy SEALs who are transitioning into and out of deployment.

Key Points: 
  • CommScope today announced the collaboration with smart home system provider Audio Impact to bring reliable Wi-Fi connectivity to Navy SEALs who are transitioning into and out of deployment.
  • The C4 Foundation uses research-proven programs to help families recover from the effects of Post-Traumatic Stress Disorder (PTSD).
  • The C4 Ranch is a unique resource for SEALs and their families, providing much-needed rest and recovery from high-pressure lives.
  • The network that connects Navy SEALs and their families at C4 Ranch is more important than ever.

AIkido Pharma Sponsors Psychedelic Compound Research to Treat PTSD

Monday, March 29, 2021 - 2:00pm

NEW YORK, March 29, 2021 /PRNewswire/ --AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that it is sponsoring psychedelic research at the Mount Sinai Center for Psychedelic Psychotherapy and Trauma Research (the "Center").

Key Points: 
  • NEW YORK, March 29, 2021 /PRNewswire/ --AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that it is sponsoring psychedelic research at the Mount Sinai Center for Psychedelic Psychotherapy and Trauma Research (the "Center").
  • The Center examines the therapeutic potential of psychedelic compounds for post-traumatic stress disorder (PTSD) and other trauma-related symptoms.
  • Each year, over 8.6 million adults grapple with PTSD, and nearly ten percent of Americans will experience PTSD at some time in their lives.
  • Currently, no academic institution, other than the Center, is conducting research involving the administration of psychedelics inside the VA System.

BlazeSports America Launches New Veteran Programs to Assist Those With PTSD and PTS

Monday, March 29, 2021 - 1:00pm

BlazeSports America , a nonprofit organization founded after the 1996 Atlanta Paralympic Games and a leader in the field of adaptive sports and recreation, announces the expansion of their Veteran Programs to include veterans with PTSD and or PTS.

Key Points: 
  • BlazeSports America , a nonprofit organization founded after the 1996 Atlanta Paralympic Games and a leader in the field of adaptive sports and recreation, announces the expansion of their Veteran Programs to include veterans with PTSD and or PTS.
  • With approximately 600,000 veterans in the state of Georgia, BlazeSports welcomes participants in their new programs created to further assist veterans.
  • BlazeSports is one of a few organizations in Metro Atlanta area that provides weekly assistance to these veterans as opposed to one-time events.
  • BlazeSports America is the direct legacy 501(c)(3) nonprofit organization of the 1996 Atlanta Paralympic Games serving children, youth, and Veterans with disabilities through programs, training and education initiatives.

Wounded Warrior Project Enlists Expert Partnership for Veteran Brain Research

Wednesday, March 24, 2021 - 11:47am

"Taking on brain injury is a priority at Wounded Warrior Project, so spreading the word is vital," said Alex Balbir, PhD, MBA, WWP Independence Services Director.

Key Points: 
  • "Taking on brain injury is a priority at Wounded Warrior Project, so spreading the word is vital," said Alex Balbir, PhD, MBA, WWP Independence Services Director.
  • In WWP's 2020 Annual Warrior Survey, more than one in three warriors report experiencing a TBI during their service.
  • WWP's Warrior Care Network is a partnership with four top academic medical centers that treat post-traumatic stress disorder and TBI.
  • Nearly 8,000 people, including more than 1,000 veterans, have pledged to donate their brain to support CTE research.

Bozeman VA Clinic to Treat Post-Traumatic Stress With Virtual Reality System Donated by Nonprofit SoldierStrong

Tuesday, March 23, 2021 - 9:48pm

BOZEMAN, Mont., March 23, 2021 (GLOBE NEWSWIRE) -- The Bozeman VA Clinic is the countrys latest Department of Veterans Affairs facility to partner with national nonprofit SoldierStrong to provide a groundbreaking virtual reality system known as BraveMind to aid in treating veterans experiencing post-traumatic stress.

Key Points: 
  • BOZEMAN, Mont., March 23, 2021 (GLOBE NEWSWIRE) -- The Bozeman VA Clinic is the countrys latest Department of Veterans Affairs facility to partner with national nonprofit SoldierStrong to provide a groundbreaking virtual reality system known as BraveMind to aid in treating veterans experiencing post-traumatic stress.
  • This donation is the 15th BraveMind system donated to a VA hospital since late 2019.
  • This is the first BraveMind virtual reality system in the state, making its treatment accessible to Montanas veterans for the first time.
  • Utilizing the virtual reality technology in BraveMind gets Veterans to talk about things theyve never talked to anyone about before, Rizzo said.